Bausch Health Companies (BHC) Exchange Rate Effect (2009 - 2026)
Bausch Health Companies (BHC) posted Exchange Rate Effect of -$2.0 million for Q2 2026, up 50.0% sequentially from -$4.0 million in Q1 2026, and down 105.13% YoY from $39.0 million in Q2 2025.
Bausch Health Companies (BHC) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Exchange Rate Effect for 18 years, with the latest figure at -$2.0 million in Q2 2026.
- Quarterly Exchange Rate Effect fell 105.13% year-over-year to -$2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.0 million (down 113.16% YoY) and the FY2025 annual result came in at $61.0 million, up 269.44% from the prior year.
- Exchange Rate Effect rose to -$2.0 million in Q2 2026 per BHC's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $39.0 million in Q2 2025 and troughed at -$35.0 million in Q4 2024.
- A 5-year average of $277777.8 and a median of -$3.0 million in 2026 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect jumped 875.0% in 2022, then slumped 1000.0% in 2024.
- Over 5 years, Exchange Rate Effect stood at $31.0 million in 2022, then plunged by 38.71% to $19.0 million in 2023, then slumped by 284.21% to -$35.0 million in 2024, then jumped by 120.0% to $7.0 million in 2025, then slumped by 128.57% to -$2.0 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$2.0 million, -$4.0 million, and $7.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | -2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.00 Mn |
| Jun 30, 2026 | -2.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Dec 31, 2024 | -35.00 Mn |
| Dec 31, 2024 | -35.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Mar 31, 2024 | -5.00 Mn |